Table 8.
Median regression model of RBD (receptor-binding domain) IgG BAU/ml at 2 weeks after second dose
| Univariable |
Multivariable |
|||
|---|---|---|---|---|
| β (95% CI) | p | β (95% CI) | p | |
| Age 70+ | −3084 (323, −955) | <0.0001 | −1914 (−2581, −1308) | <0.0001 |
| Female or non-binary | 965 (296, 326) | 0.0011 | 507 (225, 867) | 0.013 |
| Cardiovascular Disease | −1115 (285, −391) | 0.0001 | −280 (−632, 120) | 0.19 |
| Cancer | −1053 (334, −315) | 0.0017 | −495 (−837, −193) | 0.0094 |
| Diabetes | −1153 (390, −296) | 0.0032 | −258 (−758, 359) | 0.52 |
| Transplant or Immunosuppressed | −1112 (755, −147) | 0.14 | −582 (−1289, 92.6) | 0.16 |
| BMI (per +10) | 531 (168, 971) | 0.063 | 853 (368, 1067) | 0.00011 |
| Ever had positive COVID test | 1620 (1788, 90.6) | 0.37 | 1507 (192, 2710) | 0.070 |
| Any mRNA-1273 Doses | 3117 (317, 985) | <0.0001 | 2225 (1613, 2762) | <0.0001 |
| White | −1514 (508, −298) | 0.0029 | n/a | |
BMI, body mass index; CI, confidence interval; n/a, not applicable; RBD, receptor-binding domain.